138 related articles for article (PubMed ID: 9689679)
1. [Current state of knowledge concerning the mechanisms of action of BCG].
Patard JJ; Guillé F; Lobel B; Abbou CC; Chopin D
Prog Urol; 1998 Jun; 8(3):415-21. PubMed ID: 9689679
[TBL] [Abstract][Full Text] [Related]
2. [Mechanisms of action of BCG: towards a new individualized therapeutic approach?].
Saint F; Patard JJ; Salomon L; Alamé W; Cicco A; Abbou CC; Chopin D
Prog Urol; 2000 Dec; 10(6):1118-26. PubMed ID: 11217546
[TBL] [Abstract][Full Text] [Related]
3. Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells.
Brandau S; Suttmann H; Riemensberger J; Seitzer U; Arnold J; Durek C; Jocham D; Flad HD; Böhle A
Clin Cancer Res; 2000 Sep; 6(9):3729-38. PubMed ID: 10999767
[TBL] [Abstract][Full Text] [Related]
4. In vitro generation of bacillus Calmette-Guérin-activated killer cells.
Brandau S; Böhle A; Thanhäuser A; Ernst M; Mattern T; Ulmer AJ; Flad HD
Clin Infect Dis; 2000 Sep; 31 Suppl 3():S94-S100. PubMed ID: 11010832
[TBL] [Abstract][Full Text] [Related]
5. Murine IL-2 secreting recombinant Bacillus Calmette-Guerin augments macrophage-mediated cytotoxicity against murine bladder cancer MBT-2.
Yamada H; Matsumoto S; Matsumoto T; Yamada T; Yamashita U
J Urol; 2000 Aug; 164(2):526-31. PubMed ID: 10893638
[TBL] [Abstract][Full Text] [Related]
6. BCG induced CD4+ cytotoxic T cells from BCG vaccinated healthy subjects: relation between cytotoxicity and suppression in vitro.
Mustafa AS; Godal T
Clin Exp Immunol; 1987 Aug; 69(2):255-62. PubMed ID: 2958195
[TBL] [Abstract][Full Text] [Related]
7. [The need of prolonged BCG treatment in superficial bladder cancer is suggested by the development of a peripheral immune response induced by BCG].
Shekarsarai H; Zlotta AR; Drowart A; Van Vooren JP; De Cock M; Pirson M; Palfliet K; Jurion F; Vanonckelen A; Simon J; Schulman CC; Huygen K
Acta Urol Belg; 1997 Mar; 65(1):1-4. PubMed ID: 9245197
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effects of recombinant BCG and interleukin-12 DNA vaccines on xenografted murine bladder cancer.
Yu DS; Lee CF; Hsieh DS; Chang SY
Urology; 2004 Mar; 63(3):596-601. PubMed ID: 15028475
[TBL] [Abstract][Full Text] [Related]
9. Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination.
Young SL; Slobbe L; Wilson R; Buddle BM; de Lisle GW; Buchan GS
Infect Immun; 2007 Jun; 75(6):2833-40. PubMed ID: 17371857
[TBL] [Abstract][Full Text] [Related]
10. Complement C5a anaphylatoxin is an innate determinant of dendritic cell-induced Th1 immunity to Mycobacterium bovis BCG infection in mice.
Moulton RA; Mashruwala MA; Smith AK; Lindsey DR; Wetsel RA; Haviland DL; Hunter RL; Jagannath C
J Leukoc Biol; 2007 Oct; 82(4):956-67. PubMed ID: 17675563
[TBL] [Abstract][Full Text] [Related]
11. Immune responses detected in urothelial carcinoma patients after vaccination with NY-ESO-1 protein plus BCG and GM-CSF.
Sharma P; Bajorin DF; Jungbluth AA; Herr H; Old LJ; Gnjatic S
J Immunother; 2008; 31(9):849-57. PubMed ID: 18833002
[TBL] [Abstract][Full Text] [Related]
12. Internalization of Mycobacterium bovis, Bacillus Calmette Guerin, by bladder cancer cells is cytotoxic.
Pook SH; Rahmat JN; Esuvaranathan K; Mahendran R
Oncol Rep; 2007 Nov; 18(5):1315-20. PubMed ID: 17914591
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of action of intravesical bacille Calmette-Guérin: local immune mechanisms.
Prescott S; Jackson AM; Hawkyard SJ; Alexandroff AB; James K
Clin Infect Dis; 2000 Sep; 31 Suppl 3():S91-3. PubMed ID: 11010831
[TBL] [Abstract][Full Text] [Related]
14. The antigen-specific memory CD8+ T-cell response induced by BCG in cattle resides in the CD8+gamma/deltaTCR-CD45RO+ T-cell population.
Hogg AE; Worth A; Beverley P; Howard CJ; Villarreal-Ramos B
Vaccine; 2009 Jan; 27(2):270-9. PubMed ID: 18996428
[TBL] [Abstract][Full Text] [Related]
15. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin.
Batoni G; Esin S; Favilli F; Pardini M; Bottai D; Maisetta G; Florio W; Campa M
Scand J Immunol; 2005 Dec; 62(6):498-506. PubMed ID: 16316416
[TBL] [Abstract][Full Text] [Related]
16. Reduction of side effects of intravesical therapy with bacille Calmette-Guérin by pentoxifylline?--an in vitro approach.
Böhle A; Thanhäuser A; Ernst M; Flad HD; Rüsch-Gerdes S; Jocham D; Ulmer AJ
Clin Infect Dis; 2000 Sep; 31 Suppl 3():S101-5. PubMed ID: 11010833
[TBL] [Abstract][Full Text] [Related]
17. NK-like CD8(+) cells in immunologically naïve neonatal calves that respond to dendritic cells infected with Mycobacterium bovis BCG.
Hope JC; Sopp P; Howard CJ
J Leukoc Biol; 2002 Feb; 71(2):184-94. PubMed ID: 11818438
[TBL] [Abstract][Full Text] [Related]
18. Systemic and local immunomodulatory effects of intravesical BCG therapy in patients with superficial urinary bladder carcinomas.
Elsässer-Beile U; Gutzeit O; Bauer S; Katzenwadel A; Schultze-Seemann W; Wetterauer U
J Urol; 2000 Jan; 163(1):296-9. PubMed ID: 10604379
[TBL] [Abstract][Full Text] [Related]
19. Induction of bacillus-Calmette-Guérin-activated killer cells from human peripheral blood mononuclear cells against human bladder carcinoma cell lines in vitro.
Thanhäuser A; Böhle A; Flad HD; Ernst M; Mattern T; Ulmer AJ
Cancer Immunol Immunother; 1993 Jul; 37(2):105-11. PubMed ID: 8319241
[TBL] [Abstract][Full Text] [Related]
20. Bacillus Calmette-Guérin-pulsed dendritic cells stimulate natural killer T cells and gammadeltaT cells.
Naoe M; Ogawa Y; Takeshita K; Morita J; Iwamoto S; Miyazaki A; Yoshida H
Int J Urol; 2007 Jun; 14(6):532-8; discussion 538. PubMed ID: 17593099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
